Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 171,017,776
  • Shares Outstanding, K 5,666,593
  • Annual Sales, $ 58,496 M
  • Annual Income, $ 2,119 M
  • 60-Month Beta 0.69
  • Price/Sales 2.90
  • Price/Cash Flow 9.91
  • Price/Book 1.80
Trade PFE with:

Options Overview Details

View History
  • Implied Volatility 28.29% ( +1.15%)
  • Historical Volatility 19.52%
  • IV Percentile 75%
  • IV Rank 65.05%
  • IV High 33.73% on 10/27/23
  • IV Low 18.16% on 05/13/24
  • Put/Call Vol Ratio 0.38
  • Today's Volume 285,553
  • Volume Avg (30-Day) 170,430
  • Put/Call OI Ratio 1.13
  • Today's Open Interest 2,742,048
  • Open Int (30-Day) 2,815,135

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.45
  • Number of Estimates 8
  • High Estimate 0.54
  • Low Estimate 0.34
  • Prior Year 0.67
  • Growth Rate Est. (year over year) -32.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.07 +13.67%
on 06/27/24
30.93 -0.52%
on 07/25/24
+3.35 (+12.22%)
since 06/26/24
3-Month
25.54 +20.48%
on 04/29/24
30.93 -0.52%
on 07/25/24
+5.37 (+21.14%)
since 04/26/24
52-Week
25.20 +22.10%
on 04/26/24
37.19 -17.25%
on 08/21/23
-6.44 (-17.31%)
since 07/26/23

Most Recent Stories

More News
3 Surprisingly Underrated Stocks to Buy Right Now

These stocks arguably deserve more respect from investors.

XLV : 149.96 (+0.56%)
AZN : 78.13 (-0.50%)
PFE : 30.77 (+3.39%)
VTRS : 12.08 (+2.72%)
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected

EQNX::TICKER_START (NASDAQ:TNXP),(NYSE:PFE),(NYSE:LLY),(NYSE:ABBV),(NASDAQ:AXSM) EQNX::TICKER_END

TNXP : 0.5500 (-5.09%)
LLY : 804.62 (-2.02%)
PFE : 30.77 (+3.39%)
ABBV : 185.16 (+1.64%)
AXSM : 86.53 (+0.64%)
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected

TNXP : 0.5500 (-5.09%)
LLY : 804.62 (-2.02%)
PFE : 30.77 (+3.39%)
ABBV : 185.16 (+1.64%)
AXSM : 86.53 (+0.64%)
3 Stocks That Can Help You to Get Richer in 2024 and Beyond

Good bargains still abound in the market, and two of the stocks below offer fat dividends as well.

PFE : 30.77 (+3.39%)
PAYC : 164.03 (+0.70%)
GILD : 77.01 (+0.65%)
Beware, Wegovy -- Pfizer Is Working on a Competitor

Pfizer wants to maintain its recent run of key approvals.

PFE : 30.77 (+3.39%)
NVO : 126.73 (-0.88%)
Alphabet and Tesla Lead Tech Rout: Investors Reassess AI Frenzy

Wall Street faced a significant setback as the megacap earnings season got off to a disappointing start, raising concerns that the artificial intelligence (AI) frenzy fueling the bull market may be overblown....

TSLA : 219.80 (-0.20%)
TXN : 201.99 (+2.45%)
T : 19.01 (-0.94%)
V : 259.46 (+2.25%)
PFE : 30.77 (+3.39%)
BXMT : 17.59 (+1.03%)
CRWD : 256.16 (+0.79%)
This Promising Weight Loss Drug Candidate Could Be a Huge Growth Catalyst for Pfizer

With danuglipron, Pfizer could become a major player in the massive GLP-1 agonist market.

PFE : 30.77 (+3.39%)
Better Dark Horse Weight Loss Drug Stock: Pfizer vs. Roche

Neither is a leader right now, but one of them might be on track to change that.

LLY : 804.62 (-2.02%)
PFE : 30.77 (+3.39%)
RHHBY : 40.7600 (+3.03%)
Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?

The Baker brothers are billionaires with a successful track record in the biopharmaceutical industry.

MRK : 125.26 (-0.47%)
LLY : 804.62 (-2.02%)
PFE : 30.77 (+3.39%)
OPHLY : 4.9100 (+1.45%)
ABCL : 3.26 (+5.16%)
FATE : 5.44 (+0.74%)
Could Pfizer Become a Top Weight Loss Drug Stock? Don't Count on It.

The pharma's latest push to develop a weight loss pill isn't going well.

LLY : 804.62 (-2.02%)
PFE : 30.77 (+3.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 31.97
2nd Resistance Point 31.42
1st Resistance Point 31.10
Last Price 30.77
1st Support Level 30.23
2nd Support Level 29.68
3rd Support Level 29.36

See More

52-Week High 37.19
Fibonacci 61.8% 32.61
Fibonacci 50% 31.19
Last Price 30.77
Fibonacci 38.2% 29.78
52-Week Low 25.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar